Savara Inc Investment Owned, at Cost
Savara Inc (SVRA) had Investment Owned, at Cost of $2.74 million as of 2016-12-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes
us-gaap:InvestmentOwnedAtCost · last filed 2017-05-09
- 2016-12-31: Investment Owned, at Cost $2.74M.
- 2016-09-30: Investment Owned, at Cost $6.42M.
- 2016-06-30: Investment Owned, at Cost $10.57M.
- 2016-03-31: Investment Owned, at Cost $13.56M.
| Period end | Investment Owned, at Cost | Investment Owned, at Cost as first filed |
|---|---|---|
| 2016-12-31 | $2.74M 10-Q · filed 2017-05-09 | |
| 2016-09-30 | $6.42M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $10.57M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $13.56M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $17.95M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $17.70M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $22.16M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $21.95M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $21.51M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $17.12M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $20.09M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $19.80M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $18.73M 10-K · filed 2015-03-24 | $18.73M 10-K · filed 2014-03-26 |
| 2013-09-30 | $19.16M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $8.46M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $10.61M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $14.01M 10-K · filed 2013-03-19 | |
| 2012-09-30 | $13.81M 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |